Details for New Drug Application (NDA): 011496
✉ Email this page to a colleague
NDA 011496 describes ACTIDIL, which is a drug marketed by Glaxosmithkline and is included in two NDAs. Additional details are available on the ACTIDIL profile page.
The generic ingredient in ACTIDIL is triprolidine hydrochloride. There are thirteen drug master file entries for this compound. Additional details are available on the triprolidine hydrochloride profile page.
The generic ingredient in ACTIDIL is triprolidine hydrochloride. There are thirteen drug master file entries for this compound. Additional details are available on the triprolidine hydrochloride profile page.
Summary for 011496
| Tradename: | ACTIDIL |
| Applicant: | Glaxosmithkline |
| Ingredient: | triprolidine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 011496
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 1.25MG/5ML | ||||
| Approval Date: | Jul 1, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
